Lawrence Von Karsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lawrence Von Karsa has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
J. Patnick
NHS Cancer Screening Programmes Sheffield, United Kingdom
3 shared publications- Nereo Segnan
CPO Piedmont, University Hospital "Città della Salute e della Scienza", Turin, Italy
3 shared publications A. Anttila
Finnish Cancer Registry, Helsinki, Finland
2 shared publications- Catherine Sauvaget
International Agency for Research on Cancer, Lyon, France
2 shared publications R. Lambert
International Agency for Research on Cancer, Lyon, France
2 shared publicationsA. Flugelman
37 National Israeli Breast and Colorectal Cancer Detection, Haifa, Israel
1 shared publication
Latest Publications
- Open Access
- 9 May 2013
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 55 (3) , 318-328
Development and implementation of guidelines for quality assurance in breast cancer screening: The European experience
In Europe, as in many other regions of the world, breast cancer is a major cause of suffering and death. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. Comprehensive quality assurance guidelines for breast cancer screening ba- sed on mammography have been developed in the Europe Against Cancer programme with the aim of maximising screening benefits while minimising adverse effects, such as unnecessary examination or treatment resulting from false-positive screening tests. The present report provides an overview of the European experience in developing and implementing quality assurance guidelines for breast cancer screening. It highlights implications relevant to those regions of the world in which the burden of breast cancer in the coming years will make population-based screening an option for cancer control.
- 9 May 2013
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 55 (3) , 318-328
Open AccessDevelopment and implementation of guidelines for quality assurance in breast cancer screening: The European experience
In Europe, as in many other regions of the world, breast cancer is a major cause of suffering and death. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. Comprehensive quality assurance guidelines for breast cancer screening ba- sed on mammography have been developed in the Europe Against Cancer programme with the aim of maximising screening benefits while minimising adverse effects, such as unnecessary examination or treatment resulting from false-positive screening tests. The present report provides an overview of the European experience in developing and implementing quality assurance guidelines for breast cancer screening. It highlights implications relevant to those regions of the world in which the burden of breast cancer in the coming years will make population-based screening an option for cancer control.
- Open Access
- 4 December 2012
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 45 (01) , 51-59
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication
Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines. † Deceased
- 4 December 2012
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 45 (01) , 51-59
Open AccessEuropean guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication
Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines. † Deceased
- 25 September 2012
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 44 (S 03) , SE1-SE8
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Executive summary
Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The content of the executive summary is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of screening programmes and services.
- 25 September 2012
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 44 (S 03) , SE1-SE8
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Executive summary
Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The content of the executive summary is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of screening programmes and services.
- 1 August 2010
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 24 (4) , 381-396
The dimensions of the CRC problem
- 1 August 2010
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 24 (4) , 381-396
The dimensions of the CRC problem
- Top Cited PapersOpen Access
- 1 March 2010
- Published by Elsevier in Annals of Oncology
- Vol. 21 (3) , 448-458
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document
European Guidelines for Quality Assurance in Cervical Cancer Screening have been initiated in the Europe Against Cancer Programme. The first edition established the principles of organised population-based screening and stimulated numerous pilot projects. The second multidisciplinary edition was published in 2008 and comprises ∼250 pages divided into seven chapters prepared by 48 authors and contributors. Considerable attention has been devoted to organised, population-based programme policies which minimise adverse effects and maximise benefits of screening. It is hoped that this expanded guidelines edition will have a greater impact on countries in which screening programmes are still lacking and in which opportunistic screening has been preferred in the past. Other methodological aspects such as future prospects of human papillomavirus testing and vaccination in cervical cancer control have also been examined in the second edition; recommendations for integration of the latter technologies into European guidelines are currently under development in a related project supported by the European Union Health Programme. An overview of the fundamental points and principles that should support any quality-assured screening programme and key performance indicators are presented here in a summary document of the second guidelines edition in order to make these principles and standards known to a wider scientific community.
- 1 March 2010
- Published by Elsevier in Annals of Oncology
- Vol. 21 (3) , 448-458
Top Cited PapersOpen AccessEuropean Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document
European Guidelines for Quality Assurance in Cervical Cancer Screening have been initiated in the Europe Against Cancer Programme. The first edition established the principles of organised population-based screening and stimulated numerous pilot projects. The second multidisciplinary edition was published in 2008 and comprises ∼250 pages divided into seven chapters prepared by 48 authors and contributors. Considerable attention has been devoted to organised, population-based programme policies which minimise adverse effects and maximise benefits of screening. It is hoped that this expanded guidelines edition will have a greater impact on countries in which screening programmes are still lacking and in which opportunistic screening has been preferred in the past. Other methodological aspects such as future prospects of human papillomavirus testing and vaccination in cervical cancer control have also been examined in the second edition; recommendations for integration of the latter technologies into European guidelines are currently under development in a related project supported by the European Union Health Programme. An overview of the fundamental points and principles that should support any quality-assured screening programme and key performance indicators are presented here in a summary document of the second guidelines edition in order to make these principles and standards known to a wider scientific community.